INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT International Peer Reviewed & Refereed Journals, Open Access Journal ISSN Approved Journal No: 2456-4184 | Impact factor: 8.76 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)
Telomerase, a specialized reverse transcriptase enzyme, plays a crucial role in maintaining telomere length and cellular immortality. In most somatic cells, telomerase activity is low or absent, leading to progressive telomere shortening with each cell division and eventual cellular senescence. However, in cancer cells, telomerase is frequently reactivated, allowing for indefinite cell division and contributing to tumour growth and progression. Targeting telomerase activity has emerged as a promising therapeutic strategy for cancer treatment. This review study provides an in-depth analysis of the current knowledge on preventing the cancer cell progression by using telomerase inhibitors, focusing on the mechanisms of telomerase inhibitors, preclinical and clinical studies, challenges, and future prospects.
"Inhibition of Telomerase Activity in Cancer Cell Progression: A Promising Therapeutic Avenue", International Journal of Novel Research and Development (www.ijnrd.org), ISSN:2456-4184, Vol.8, Issue 7, page no.d155-d159, July-2023, Available :http://www.ijnrd.org/papers/IJNRD2307319.pdf
Downloads:
000118768
ISSN:
2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar| ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Facebook Twitter Instagram LinkedIn